The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
lol... thought you were gonna say something different.... yes, I saw that 3 days ago before boarding the ship
what are you implying Firwood?
Yes Firwood, they are trying to scare PI's and trigger stop losses to their advantage. Best to hold.. it will fly soon. IMO.. way over cooked
MM's showing buys as sells!! all buys from last hour showing as sells.
58.55 paid
Well, lets get it going then lol
Ready to bounce... i wonder gla
Hi Pred... you have a valid point with regards to current market conditions. If we look around almost all big/small caps going through correction. At times, it sucks but is an integral part of the journey into a more loved bull market.. I reckon quiz will bounce given current market value, net assets circa. 20.5 million plus years of experience and recent own website growth and penetration into other markets should manifest itself. For me, its an opportunity with reasonable risk/reward. Gla... dyor
Next week will be very interesting IMO. Have been holding this for good few months now. I feel the market is a bit cautious for the moment and couple of RNS shortly after euro trial didn't help either. Financial position (balance sheet) and future statement regards to future of flagship drug would be key indications. I am hoping they announce something positive from japs study. All the best and good luck to all holders
Some folks are very fascinating.... just over two days ago when jambon and Putneylad were appraising the company... "Alrighty then" was trolling like he had been paid to do his duty diligently.... lol... shame how to get a few pence cheap... ppl change their colours...
Ester, i think you have got your wires crossed... €21 million was loss (mostly R&D) that can be offset against future profits... (all companies do that for tax purposes) They had around €18 million at the end of Apr-18, it will obviously be less now due to admin & operation al expenses... equity raise might be on the cards... maybe in 2/3 months or so.... but having said all that still doesn't mean that company is a failure... Look around and you will find most companies have to raise funds at some point to keep moving on... i believe in the science and company's ambition to bring something innovative to help people suffering from acute conditions... gd luck to all genuine holders
Ester, agree this one has value and hence why I am invested here... not with 1 or 2k with values some can only dream off...
I am patiently waiting for Japanese results.. that's where the value lies... Clevegen is also encouraging and has good value